Latest Fitness News

2Oct
2022

Are Your Hands Just Dry, Or Is It Eczema?

Are Your Hands Just Dry, Or Is It Eczema?SUNDAY, Oct. 2, 2022 (HealthDay News) -- Sometimes that irritated skin on your hands is more than simple dryness. Hand eczema could be the culprit, with painful dry and itchy skin on all or part of the hand and fingers."If your hands are extremely dry and painful, and using moisturizer throughout the day is not helping to relieve them, you may have hand eczema," said Dr. Dawn Davis, a pediatric and adult dermatologist at the Mayo Clinic in Rochester, Minn. "Without the proper treatment and preventive measures, hand eczema may worsen."Eczema might look like patches of red, dark brown, purple or gray irritated skin, according to the American Academy of Dermatology. It can be scaly, inflamed and itchy. It can feel like it's burning or include itchy blisters and deep, painful cracks, as...

Get Ready for Those Fall Allergies

1 October 2022
Get Ready for Those Fall AllergiesSATURDAY, Oct. 1, 2022 (HealthDay News) -- Allergy sufferers know that symptoms don’t just appear in spring or summer. Fall, too, can bring about sneezing and trouble breathing, as can volatile weather patterns.“People frequently experience allergy symptoms in the fall even if they are mainly allergic to pollens in the spring and summer,” said Dr. David Corry. He is a professor of medicine in the section of immunology, allergy and rheumatology at Baylor College of Medicine in Houston.Among the natural events that could affect allergy sufferers this year are the Tonga Volcano eruption in January, Corry said. That sent particulates and aerosols into the environment and could change global weather, shortening or lengthening upcoming pollen seasons.Those seasons could further change...

U.S. Will Spend $266 Million to Bolster Public Health...

30 September 2022
U.S. Will Spend $266 Million to Bolster Public Health ProgramsFRIDAY, Sept. 30, 2022 (HealthDay News) -- The U.S. government will invest $266 million to shore up the community and public health workforce using American Rescue Plan funding. About $225.5 million will go to 83 recipients to support training and apprenticeship for 13,000 new community health workers, CNN reported before Friday's announcement. These workers specialize in helping people find care and serve as a contact point between patients and providers."Thirty million people in America get their health care through community health centers that treat people regardless of their ability to pay," said Carole Johnson, administrator of the U.S. Department of Health and Human Services' Health Resources and Services Administration, which is facilitating the grants. "Time and time again, we...

AHA News: After a Jump in Maternal Mortality for...

30 September 2022
AHA News: After a Jump in Maternal Mortality for Hispanic Women, a Search for AnswersFRIDAY, Sept. 30, 2022 (American Heart Association News) -- The COVID-19 pandemic produced no shortage of somber statistics. But for people who care about women's health, one number about Hispanic women stood out.Their maternal mortality rate jumped sharply in 2020 – up 44% from the year before, according to the latest available data from the Centers for Disease Control and Prevention. For every 100,000 births, there were 18.2 deaths among Hispanic women, up from 12.6 in 2019. Risk was highest among women 40 and older.The increase drew attention in part because Hispanic women's maternal mortality rate had been relatively low when compared with white and Black women.Dr. Sadiya Khan, an assistant professor of medicine in the division of cardiology at Northwestern University's Feinberg...

FDA Approves New ALS Drug Despite Uncertain Data

30 September 2022
FDA Approves New ALS Drug Despite Uncertain DataFRIDAY, Sept. 30, 2022 (HealthDay News) – The U.S. Food and Drug Administration on Thursday gave its approval to a new drug for ALS (amyotrophic lateral sclerosis), also known as Lou Gehrig's disease.But approval of the drug, called Relyvrio, is bound to stir new questions, with some doubting the strength of data supporting its effectiveness. Patient advocate groups had strongly lobbied the FDA for its approval, however."This approval provides another important treatment option for ALS, a life-threatening disease that currently has no cure," Dr. Billy Dunn, director of the Office of Neuroscience in the FDA's Center for Drug Evaluation and Research, said in an agency statement. "The FDA remains committed to facilitating the development of additional ALS treatments."The drug's path to...
RSS
1345678910Last
HealthDay

Copyright © 2018 HealthDay. All rights reserved.